Independent analysis on Brazil market entry, regulated sectors, real assets, and the jurisdictional complexity that shapes returns for foreign capital.
Each note is a self-contained argument addressing one operational dimension of Brazilian markets. Collected here as a permanent reference.
The municipality where your Brazilian deal executes is a primary investment decision, not a logistical detail. A pre-commitment checklist of what foreign investors must verify before capital is committed — not after.
Read article →Brazilian healthcare fragments by municipality, and the fragmentation determines returns. What foreign investors must read first before applying U.S. or European healthcare frameworks to Brazil.
Read article →The most significant Brazilian tax reform in three decades is now in effect. What foreign investors need to understand about IBS, CBS, IRPFM, and the transition period.
Read article →The institutional research apparatus concentrates on Brazil's two largest markets. The complexity arbitrage opportunity concentrates elsewhere — in the secondary cities where the gap between described and operational reality is widest.
Read article →What Brazil's main real estate indices — FipeZAP, IBRE/FGV, IGMI-C, and IFIX — actually measure, where they reliably inform decisions, and the yield components they systematically miss.
Read article →Why U.S. and European MOB frameworks produce predictable failures in Brazil — and what replaces them. Cap rates, regulatory risk, tenant mix, and professional ecosystems rebuilt for the Brazilian market.
Read article →What a Brazil Complexity Brief is, what it is not, and how to determine whether your situation warrants one. The most useful format of inquiry explained.
Read article →In Brazil's regulated sectors, having the legal right to operate is not the same as being operationally able to. The gap between permission and feasibility is where most market entry failures occur.
Read article →Access and alignment are different variables. Most partnership failures in Brazil were visible before capital was committed — if the investor knew what to look for.
Read article →The premium on Brazilian clinical real estate is real. So is the complexity that produces it — and that most buyers do not price correctly. The activation sequence explained.
Read article →Brazil has 5,570 municipalities, each implementing the same federal framework with different administrative capacities. Municipal licensing risk is the most underestimated variable in foreign investment in Brazil — and the variable most determinative of execution timeline.
Read note →FipeZAP and aggregate benchmarks describe asking prices and aggregate yields. They do not describe activation cost, licensing delay, lease structure, or what yield actually looks like after the deal has been executed through the operational layer.
Read note →Market research describes the country. Market entry executes through the country. Confusing the two is the most common structural error in foreign market entry into Brazil — and the one most expensive to discover after capital has been committed.
Read note →The gap between a correct macro thesis about Brazil and a successful Brazilian investment is not analytical failure. It is a failure of resolution. The operational layer is where deals actually succeed or fail — and where most foreign capital does not look.
Read note →Brazilian commercial real estate rents are rising at double-digit rates while sale prices stay flat in real terms. The FipeZAP index — the primary public benchmark — is measuring the wrong variable. Inside the gap is the activation thesis.
Read note →Brazilian equities rallied thirty percent in dollar terms in 2025, yet foreign passive capital captured almost none of it. The opportunity sits in an operational layer that public benchmarks and institutional research cannot measure. Manifesto of the research series.
Read note →